ATN International, Inc.
ATN International, Inc. Reports Third Quarter 2026 Results and Updates 2026 Full Year Outlook
Reports a 32% increase in operating income and consistent year-over-year revenue and Adjusted EBITDA1
Source
From SEC EDGAR
161 releases originally issued via SEC EDGAR. The issuing organizations are responsible for their content.
HCI Group, Inc.
HCI Group Reports Third Quarter 2026 Results
Third Quarter Pre-Tax Income of $116 million
Lemaitre Vascular Inc
LeMaitre Q3 2026 Financial Results
Sturm Ruger & Co Inc
Sturm, Ruger & Company, Inc. Reports Third Quarter 2026 Results
Delivered Third Quarter Net Sales of $147.6 Million, a 16.5% Increase Year-Over-Year
Veracyte, Inc.
Veracyte Announces Third Quarter 2026 Financial Results
Grew total revenue to $151.8 million and testing revenue to $146.4 million, representing 15% year-over-year growth
Victory Capital Holdings, Inc.
Victory Capital Holdings, Inc.
Victory Capital Reports Strong Third Quarter 2026 Results, Highlighted by Record Gross Sales and Net Flows
Niagen Bioscience, Inc.
Niagen Bioscience, Inc. Reports Third Quarter 2026 Financial Results
Launched Niagen™ Plus Niagen™ Liquid At-Home Injections
Kailera Therapeutics, Inc.
Kailera Reports Third Quarter 2026 Financial Results and Provides Business Updates
Ribupatide oral global Phase 3 program expected to begin in 1H 2027 following completion of End-of-Phase 2 meeting with FDA
Relay Therapeutics, Inc.
Relay Therapeutics, Inc.
Relay Therapeutics Reports Third Quarter 2026 Financial Results and Corporate Updates
Granite Point Mortgage Trust Inc.
Granite Point Mortgage Trust Inc. Reports
Third Quarter 2026 Financial Results
Amplitude, Inc.
Amplitude Announces Third Quarter 2026 Financial Results
Annual Recurring Revenue of $431 million, up 24% year-over-year
ThredUp Inc.
ThredUp Announces Third Quarter 2026 Results
•Quarterly revenue of $88.2 million, representing an increase of 7% year-over-year
Coty Inc.
COTY ANNOUNCES FIRST QUARTER FISCAL YEAR 2027 RESULTS
Q1 Profit and EPS Ahead of Guidance; Modest Sales Decline of 1%, with LFL Sales Down 2%
Host Hotels & Resorts, Inc.
HOST HOTELS & RESORTS, INC.
Host Hotels & Resorts, Inc. Reports Results for the Third Quarter of 2026
Evommune, Inc.
Evommune Enters into Agreement to In-License EVO570, a Potential Best-in-Class Oral VAV1 Molecular Glue Degrader, from Hinova Pharmaceuticals
Oral, highly selective and potent VAV1 molecular glue degrader designed to deliver a differentiated clinical profile across a broad range of…
ZoomInfo Technologies Inc.
ZoomInfo Announces Third Quarter 2026 Financial Results
CF Industries Holdings, Inc.
CF Industries Holdings, Inc.
CF Industries Holdings, Inc. Reports First Nine Months 2026 Net Earnings of $1.78 Billion, Adjusted EBITDA of $3.01 Billion